Statistics for DexCom (id:7098 DXCM)
Valuation metrics
Market cap
29.79B
Enterprise value
29.74B
Trailing P/E (ttm)
46.22
Forward P/E
37.57
PEG ratio
37.57
Price/Sales (ttm)
7.53
Price/Book (mrq)
15.05
Enterprise Value/Revenue
7.52
Enterprise Value/EBITDA
35.38
Overview
Shares outstanding
390.60M
Float
387.52M
Shares short
9.36M
% Held by insiders
0.00%
% Held by institutions
0.97%
Average volume (10 days)
4.52M
Average volume (90 days)
Price summary
52-Week low
62.34
52-Week high
142.00
52-Week change
-56.50%
Beta
1.17
50-Day moving average
70.03
200-Day moving average
102.65
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
June 13th, 2022
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
17.22%
Operating margin
15.29%
Operational effectiveness
Return on assets
6.06%
Return on equity
32.06%
Income statement
Revenue (ttm)
10.09
Revenue per share (ttm)
10.09
Quarterly revenue growth (yoy)
0.12
Gross profit (ttm)
2.29B
EBITDA
975.30M
Net income to common (ttm)
680.80M
Diluted EPS (ttm)
1.65
Quarterly earnings growth (yoy)
11.50%
Balance sheet
Total cash (mrq)
2.49B
Total cash per share (mrq)
6.38
Total debt (mrq)
2.59B
Total Debt/Equity (mrq)
130.94
Current ratio (mrq)
245.80%
Book value per share (mrq)
5.07
Cash flow
Cash flow statement
821.70M
Levered free cash flow (LFCF)
353.22M